A $521.3 Billion Market by 2027 That includes AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi – thqaftqlm

A $521.3 Billion Market by 2027 That includes AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi

DUBLIN, April 19, 2023 /PRNewswire/ — The “International Markets for Bioengineered Protein Medicine” report has been added to  ResearchAndMarkets.com’s providing.

Research and Markets Logo

Analysis and Markets Brand

The worldwide bioengineered protein medicine market was estimated to have been price $327.6 billion in 2021. Between 2022 and 2027, the bioengineered protein medicine market is predicted to develop at a compound annual development fee (CAGR) of 8%, resulting in a market worth of $521.3 billion in 2027.

Descriptive firm profiles of the main international gamers, together with AbbVie Inc., AstraZeneca plc, GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMS) Co., Pfizer Inc., Merck and Co., and Sanofi S.A.

An growing old inhabitants with a myriad of power ailments, the necessity for more practical and focused therapeutics, and steady innovation in bioengineered protein medicine are driving the bioengineered protein medicine market.

Bioengineered protein medicine are broadly used as a consequence of their excessive specificity, enhanced efficacy, affinity, solubility, and low toxicity. Advances in protein synthesis have elevated the complexity of bioengineered proteins being produced for therapeutic functions.

Continued growth in protein drug manufacturing applied sciences, rising incidence of power ailments, the bigger aged inhabitants, improved protein-based drug efficacy, and developments in drug supply techniques will enhance the bioengineered protein medicine market. Improvements in protein medicine are accelerating shortly.

For instance, within the final two years (2021 and 2022), 43 of 112, or 38.4% of all novel drug and organic product approvals, had been for bioengineered protein medicine. The presence of excessive unmet wants and the huge potential for innovation provides large development potential for the market.

The price of growing and producing bioengineered protein medicine is dramatically greater than for typical (small molecule) medicines and entails prolonged complicated manufacturing processes and stringent regulatory necessities. The market is much less vulnerable to generic competitors than small molecule medicine.

Massive molecule or protein medicine don’t have the identical form of generic competitors as small molecule medicine and have an extended shelf-life by way of patent safety. Over the previous three many years, bioengineered protein medicine have revolutionized the remedy of infectious ailments, most cancers, and power immunological ailments.

Pharmaceutical producers are centered on growing and manufacturing novel bioengineered protein medicine for most cancers, autoimmune problems, and different life-threatening illness therapies. That is evidenced by the rising competitors within the bioengineered protein medicine market.

Report Scope

This report goals to supply a complete research of the worldwide marketplace for bioengineered protein medicine, each by way of quantitative and qualitative knowledge, to assist readers develop enterprise/development methods, assess the market panorama, analyze their place within the present market and make knowledgeable enterprise selections relating to bioengineered protein medicine. Segmentation relies on the drug kind, illness kind, and area.

Business development drivers, restraints, traits, and alternatives in bioengineered protein medicine are additionally mentioned intimately. The report additionally offers info on the bioengineered protein drug market aggressive panorama, options detailed firm profiles, and discusses the affect of COVID-19 in the marketplace.

The report consists of:

  • Analyses of the worldwide market traits, with historic market income knowledge (gross sales figures) from 2019-2021, estimates for 2022, forecasts for 2023, and projections of compound annual development charges (CAGRs) by way of 2027

  • Highlights of the rising expertise traits, alternatives and gaps estimating present and future demand for bioengineered protein medicine market, and main areas and nations concerned in market developments

  • Estimation of the particular market dimension and income forecast for international bioengineered protein medicine market in USD million phrases, and corresponding market share evaluation by drug kind, illness kind, and area

  • In-depth info (information and figures) regarding the main elements influencing the progress of this market (advantages, and industry-specific challenges) with respect to particular development traits, upcoming applied sciences, future prospects, and contributions to the general biopharmaceutical {industry}

  • Dialogue of the regulatory features and requirements for bioengineered protein therapeutics, newly authorized merchandise, underlying scientific trials for all phases and record of vaccines, and the COVID-19 affect on the progress of this market

  • Perception into the current {industry} construction, aggressive features of every product phase, rising funding on R&D actions to develop new and improved therapies, market growth methods, and firm worth share evaluation

  • Identification of the foremost firms concerned within the manufacturing and modification of protein medicine, and evaluation of the corporate aggressive panorama primarily based on their current developments, monetary efficiency, and segmental revenues

Key Matters Lined:

Chapter 1 Introduction

Chapter 2 Abstract and Highlights

Chapter 3 Market and Expertise Background
3.1 Protein Medicine Overview
3.2 Bioengineered Protein Medicine
3.3 Manufacturing Applied sciences
3.3.1 Fractionation/Extraction from Pure Sources (Human/Animal)
3.3.2 Microbial Fermentation and Bioreactors
3.3.3 Transgenics
3.3.4 Mammalian Cell Tradition

Chapter 4 Market Dynamics
4.1 Market Drivers
4.1.1 Rising and Getting old Inhabitants
4.1.2 Growing Prevalence of Power Ailments
4.1.3 Developments in Manufacturing Applied sciences
4.1.4 New Product Launches and Label Expansions
4.1.5 Premium Pricing
4.1.6 Collaborations and Licensing Agreements
4.2 Market Challenges
4.2.1 Evolving Regulatory Situation
4.2.2 Accelerating Biosimilars Market

Chapter 5 Market Breakdown by Drug Sort
5.1 Overview
5.2 Monoclonal Antibodies (mAbs)
5.3 Peptide Hormones
5.4 Vaccines
5.5 Fusion Proteins
5.6 Blood Elements
5.7 Peptide Antibiotics
5.8 Cytokines
5.9 Therapeutic Enzymes
5.10 International Marketplace for Bioengineered Protein Medicine, by Sort
5.10.1 Monoclonal Antibodies (mAbs)
5.10.2 Peptide Hormones
5.10.3 Vaccines
5.10.4 Blood Elements and Peptide Antibiotics
5.10.5 Fusion Proteins
5.10.6 Cytokines
5.10.7 Therapeutic Enzymes

Chapter 6 Market Breakdown by Illness
6.1 Overview
6.2 Autoimmune Ailments and Different Immunodeficiency Problems
6.3 Strong Tumors
6.4 Diabetes
6.4.1 Sort 1 Diabetes
6.4.2 Sort 2 Diabetes
6.4.3 Gestational Diabetes
6.5 Infectious Ailments
6.5.1 Pneumococcal
6.5.2 Diphtheria, Tetanus
6.5.3 Human Papillomavirus (HPV)
6.5.4 MMR
6.5.5 Influenza
6.5.6 Hepatitis A
6.5.7 Others
6.6 Blood Problems
6.6.1 Bleeding Problems
6.6.2 Anemia
6.6.3 Blood Most cancers
6.6.4 Paroxysmal Nocturnal Hemoglobinuria
6.7 Progress Hormone Problems, Enzyme Deficiency Problems, and Infertility
6.8 Others
6.8.1 Osteoporosis
6.8.2 Bronchial asthma
6.8.3 Eye Problems and Ailments
6.8.4 Transplants
6.8.5 Cardiovascular Ailments
6.8.6 Respiratory Syncytial Virus An infection
6.8.7 Pores and skin Ailments
6.9 International Marketplace for Bioengineered Protein Medicine, by Illness
6.9.1 Autoimmune Ailments and Different Immunodeficiency Problems
6.9.2 Strong Tumors
6.9.3 Diabetes
6.9.4 Infectious Ailments
6.9.5 Blood Problems
6.9.6 Progress Hormone Problems, Enzyme Problems, and Infertility
6.9.7 Others

Chapter 7 Market Breakdown by Area
7.1 International Markets for Bioengineered Protein Medicine, by Area
7.1.1 North America Market Income, by Drug Sort
7.1.2 Europe Market Income, by Drug Sort
7.1.3 Rising Markets Income, by Drug Sort

Chapter 8 Regulatory Facets and New Approvals
8.1 New Approvals
8.1.1 Monoclonal Antibodies (mAbs)
8.1.2 Peptide Hormones
8.1.3 Vaccines
8.1.4 Blood elements
8.1.5 Peptide Antibiotics
8.1.6 Therapeutic Enzymes
8.1.7 Cytokines
8.1.8 Fusion Protein

Chapter 9 Aggressive Panorama
9.1 Overview
9.2 Blockbuster Bioengineered Protein Pharmaceutical Manufacturers
9.3 Monoclonal Antibodies
9.3.1 Market Share
9.3.2 Ten High-Promoting Monoclonal Antibodies
9.4 Peptide Hormones
9.4.1 Market Share
9.5 Vaccines (Excluding COVID-19)
9.5.1 Market Share
9.6 Blood Elements and Peptide Antibiotics
9.6.1 Key Gamers in Recombinant Blood Elements Market
9.6.2 Key gamers in Peptide Antibiotics Market
9.7 Fusion Proteins
9.7.1 Market Share
9.8 Cytokines
9.8.1Market Share
9.9 Therapeutic Enzymes
9.9.1 Market Share

Chapter 10 Rising Developments/Upcoming Applied sciences within the Market
10.1 Bi- and Multi-Particular Antibodies
10.1.1 Oral GLP-1 Remedy
10.1.2 Accelerating Uncommon Illness Analysis Worldwide
10.2 Key Developments in Biopharmaceutical Business

Chapter 11 Impression of COVID-19 Pandemic
11.1 Overview
11.2 Impression on Bioengineered Protein Medicine Market
11.2.1 Impression on the mAbs Market
11.2.2 Impression on Peptide Hormone Market
11.2.3 Impression on Vaccines Market
11.2.4 Impression on Blood Elements and Peptide Antibiotics Market
11.2.5 Impression on Fusion Protein Market
11.2.6 Impression on Cytokines Market
11.2.7 Impression on Therapeutic Enzyme Market

Chapter 12 Firm Profiles

For extra details about this report go to https://www.researchandmarkets.com/r/weyt81

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis experiences and market knowledge. We give you the newest knowledge on worldwide and regional markets, key industries, the highest firms, new merchandise and the newest traits.

Media Contact:

Analysis and Markets
Laura Wooden, Senior Supervisor

For E.S.T Workplace Hours Name +1-917-300-0470 
For U.S./CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outdoors U.S.): +353-1-481-1716

Brand:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg



View authentic content material:https://www.prnewswire.com/news-releases/global-bioengineered-protein-drugs-markets-report-2023-a-521-3-billion-market-by-2027-featuring-abbvie-astrazeneca-glaxosmithkline-bristol-myers-squibb-pfizer-merck-and-sanofi-301802103.html

SOURCE Analysis and Markets

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top